<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0003101-Edelman1">
 <label>52</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Edelman</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Tacket</surname>
   <given-names>CO</given-names>
  </name>, 
  <name>
   <surname>Wasserman</surname>
   <given-names>SS</given-names>
  </name>, 
  <name>
   <surname>Bodison</surname>
   <given-names>SA</given-names>
  </name>, 
  <name>
   <surname>Perry</surname>
   <given-names>JG</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2000</year>) 
  <article-title>Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218</article-title>. 
  <source>Am J Trop Med Hyg</source>
  <volume>62</volume>: 
  <fpage>681</fpage>â€“
  <lpage>685</lpage>.
  <pub-id pub-id-type="pmid">11304054</pub-id>
 </mixed-citation>
</ref>
